Skip to main content

Table 2 Management experience about iron therapy in PD (topic 2)

From: Unmet needs about iron deficiency in peritoneal dialysis: a Delphi consensus panel

Statement 6

I principally treat my patient in PD with iron deficiency by:

1

2

3

4

5

 6.1 Oral iron

8%

92%

 

1

1

12

7

4

 6.2 I.V. iron

16%

84%

 

1

3

4

10

7

Statement 7

In relation to the treatment strategy, I retain that

1

2

3

4

5

 7.1 It should be modulated on correction targets set for every patient

0%

100%

 

0

0

6

8

11

 7.2 It should be a schema “low doses—high frequency”

90%

10%

 

3

16

3

3

0

 7.3 It should be a schema “high doses at a low frequency”

12%

88%

 

1

2

6

12

4

Statement 8

I retain that target values in the peritoneal dialysis patient are:

1

2

3

4

5

 8.1 TSAT not inferior to 20% and not superior to 40%

4%

96%

 

0

1

4

8

12

 8.2 TSAT not inferior to 10% and not superior to 30%

64%

36%

 

7

9

4

5

0

 8.3 TSAT not inferior to 30% and not superior to 50%

52%

48%

 

3

10

6

4

2

 8.4 Ferritine inferior to 500

20%

80%

 

0

5

7

6

7

 8.5 Ferritine inferior to 500

44%

56%

 

8

3

4

5

5

Statement 9

Referring to the fact that I.V. therapeutic strategies now available facilitate the treatment of iron deficiency in peritoneal dialysis 1 retain that

1

2

3

4

5

 9.1 The currently adopted approach is adequate for the management of the majority of patients in PD

20%

80%

 

0

5

7

8

5

 9.2 The strategies that could be applied with new molecules let both logistic issues and clinical response improve

4%

96%

 

0

1

1

9

14

 9.3 The improvement is solely about clinical response

60%

40%

 

3

12

6

4

0

 9.4 The improvement is solely about safety

60%

40%

 

3

12

7

2

1

 9.5 The improvement is solely about logistic issues

60%

40%

 

3

12

5

5

0

Statement 10

I retain that the patient with heart failure and iron deficiency in PD:

1

2

3

4

5

 10.1 Should be treated as every other patient

72%

28%

 

7

11

2

4

1

 10.2 Needs a greater attention as regards iron deficiency and a more complete and rapid correction

8%

92%

 

0

2

2

12

9

 10.3 Only cardiologic indications should be followed

92%

8%

 

9

14

1

1

0